NO975366L - Vaksine sammensetning inneholdende polyribosylribitol fosfat og fremgangsmåte for fremstilling derav - Google Patents

Vaksine sammensetning inneholdende polyribosylribitol fosfat og fremgangsmåte for fremstilling derav

Info

Publication number: NO975366L
Authority: NO; Norway
Prior art keywords: preparation; composition containing; vaccine composition; polyribosylribitol phosphate; polyribosylribitol
Prior art date: 1995-05-24

Application number

NO975366A

Other languages

English (en)

Other versions

NO319579B1 (no

NO975366D0 (no

Inventor

Francois Arminjon

Jean-Rene Cartier

Original Assignee

Pasteur Merieux Serums Vacc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-05-24

Filing date

1997-11-21

Publication date

1997-11-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9479510&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO975366(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-11-21 Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc

1997-11-21 Publication of NO975366L publication Critical patent/NO975366L/no

1997-11-21 Publication of NO975366D0 publication Critical patent/NO975366D0/no

2005-08-29 Publication of NO319579B1 publication Critical patent/NO319579B1/no

Links

229910019142 PO4 Inorganic materials 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 title abstract 2
239000010452 phosphate Substances 0.000 title abstract 2
229960005486 vaccine Drugs 0.000 title abstract 2
SGNXVBOIDPPRJJ-PSASIEDQSA-N 1-[(1r,6r)-9-azabicyclo[4.2.1]non-4-en-5-yl]ethanone Chemical compound CC(=O)C1=CCC[C@@H]2CC[C@H]1N2 SGNXVBOIDPPRJJ-PSASIEDQSA-N 0.000 abstract 1
241000606768 Haemophilus influenzae Species 0.000 abstract 1
206010043376 Tetanus Diseases 0.000 abstract 1
239000003948 anatoxin Substances 0.000 abstract 1
239000000427 antigen Substances 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
150000004676 glycans Chemical class 0.000 abstract 1
229940045808 haemophilus influenzae type b Drugs 0.000 abstract 1
229920001282 polysaccharide Polymers 0.000 abstract 1
239000005017 polysaccharide Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

NO19975366A 1995-05-24 1997-11-21 Vaksine sammensetning inneholdende hoymolekylaert polyribosylribitolfosfat, og fremgangsmate for fremstilling derav NO319579B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9506417A FR2734484B1 (fr)	1995-05-24	1995-05-24	Composition vaccinale liquide et procede de fabrication
PCT/FR1996/000791 WO1996037222A1 (fr)	1995-05-24	1996-05-24	Composition vaccinale comprenant du polyribosylribitol phosphate et son procede de fabrication

Publications (3)

Publication Number	Publication Date
NO975366L true NO975366L (no)	1997-11-21
NO975366D0 NO975366D0 (no)	1997-11-21
NO319579B1 NO319579B1 (no)	2005-08-29

Family

ID=9479510

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO19975366A NO319579B1 (no)	1995-05-24	1997-11-21	Vaksine sammensetning inneholdende hoymolekylaert polyribosylribitolfosfat, og fremgangsmate for fremstilling derav
NO2011019C NO2011019I2 (no)	1995-05-24	2011-09-19	Vaksine omfattende antigenet PRP-T koplet til et tetanus anatoksin

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO2011019C NO2011019I2 (no)	1995-05-24	2011-09-19	Vaksine omfattende antigenet PRP-T koplet til et tetanus anatoksin

Country Status (25)

Country	Link
US (1)	US6333036B1 (no)
EP (1)	EP0828511B1 (no)
JP (1)	JPH11505824A (no)
KR (1)	KR100404312B1 (no)
CN (1)	CN1152715C (no)
AT (1)	ATE207365T1 (no)
BR (1)	BR9608810C8 (no)
CA (1)	CA2218764C (no)
CZ (1)	CZ289810B6 (no)
DE (2)	DE122011100030I1 (no)
DK (1)	DK0828511T3 (no)
EA (1)	EA000411B1 (no)
ES (1)	ES2162067T3 (no)
FR (1)	FR2734484B1 (no)
GR (1)	GR3037011T3 (no)
HU (1)	HU223941B1 (no)
LU (1)	LU91924I2 (no)
NL (1)	NL300231I2 (no)
NO (2)	NO319579B1 (no)
NZ (1)	NZ309829A (no)
PL (1)	PL185846B1 (no)
PT (1)	PT828511E (no)
SK (1)	SK282500B6 (no)
TR (1)	TR199701424T1 (no)
WO (1)	WO1996037222A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020054884A1 (en)	1995-06-23	2002-05-09	Smithkline Beecham Biologicals, Sa	Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
US6974581B1 (en) *	1998-12-15	2005-12-13	Aventis Pasteur Limited	Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease
IL145209A0 (en)	2000-09-06	2002-06-30	Pfizer Prod Inc	Pharmaceutical combinations for the treatment of stroke and traumatic brain injury
EP1674087A1 (en)	2000-10-02	2006-06-28	Pfizer Products Inc.	Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists
FR2828406B1 (fr) *	2001-08-08	2005-06-24	Aventis Pasteur	Composition vaccinale bivalente havi
HUE031886T2 (en)	2002-10-11	2017-08-28	Glaxosmithkline Biologicals Sa	Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines
EP2172213B1 (en)	2003-01-30	2013-04-03	Novartis AG	Injectable vaccines against multiple meningococcal serogroups
GB0313916D0 (en) *	2003-06-16	2003-07-23	Glaxosmithkline Biolog Sa	Vaccine composition
NZ546430A (en)	2003-10-02	2009-04-30	Novartis Vaccines & Diagnostic	Liquid vaccines for multiple meningococcal serogroups
GB0323103D0 (en)	2003-10-02	2003-11-05	Chiron Srl	De-acetylated saccharides
US7671072B2 (en) *	2003-11-26	2010-03-02	Pfizer Inc.	Aminopyrazole derivatives as GSK-3 inhibitors
GB0405787D0 (en) *	2004-03-15	2004-04-21	Chiron Srl	Low dose vaccines
GB0409745D0 (en)	2004-04-30	2004-06-09	Chiron Srl	Compositions including unconjugated carrier proteins
NZ550533A (en)	2004-04-30	2010-02-26	Novartis Vaccines & Diagnostic	Meningococcal conjugate vaccination comprising N. meningitidis and diphtheria toxin
GB0500787D0 (en)	2005-01-14	2005-02-23	Chiron Srl	Integration of meningococcal conjugate vaccination
CA2694083A1 (en) *	2007-07-26	2009-01-29	Sanofi Pasteur Limited	Antigen-adjuvant compositions and methods
GB0818453D0 (en)	2008-10-08	2008-11-12	Novartis Ag	Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
PE20100366A1 (es) *	2008-10-24	2010-05-21	Panacea Biotec Ltd	Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion
PE20100365A1 (es)	2008-10-24	2010-05-21	Panacea Biotec Ltd	Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion
US7814991B2 (en) *	2009-01-28	2010-10-19	Gas Technology Institute	Process and apparatus for subterranean drilling
EP2411048B1 (en)	2009-03-24	2020-05-06	GlaxoSmithKline Biologicals SA	Adjuvanting meningococcal factor h binding protein
CA2793580A1 (en) *	2010-03-29	2011-10-06	Novartis Ag	Composition comprising the amyloid beta 1-6 peptide coupled to a virus-like particle and an adjuvant
EP2661277A2 (en)	2011-01-05	2013-11-13	Bharat Biotech International Limited	A combination heptavalent vaccine
WO2014135651A1 (en)	2013-03-08	2014-09-12	Crucell Holland B.V.	Acellular pertussis vaccine
KR102861088B1 (ko)	2021-04-20	2025-09-17	케이엠 바이올로직스 가부시키가이샤	6종 혼합 액상 백신 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1209036A (en) *	1982-08-20	1986-08-05	Joseph S.C. Kuo	Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
IT1187753B (it) *	1985-07-05	1987-12-23	Sclavo Spa	Coniugati glicoproteici ad attivita' immunogenica trivalente
EP0320942A3 (en) *	1987-12-18	1989-10-04	American Cyanamid Company	Novel polysaccharides novel macromolecular conjugates of the polysaccharides
GB9202219D0 (en) *	1992-02-03	1992-03-18	Connaught Lab	A synthetic heamophilus influenzae conjugate vaccine
SG48365A1 (en) *	1992-05-23	1998-04-17	Smithkline Beecham Biolog	Combined vaccines comprising hepatitis b surface antigen and other antigens

1995
- 1995-05-24 FR FR9506417A patent/FR2734484B1/fr not_active Expired - Lifetime
1996
- 1996-05-24 CZ CZ19973597A patent/CZ289810B6/cs not_active IP Right Cessation
- 1996-05-24 CA CA2218764A patent/CA2218764C/fr not_active Expired - Lifetime
- 1996-05-24 AT AT96917554T patent/ATE207365T1/de active
- 1996-05-24 DK DK96917554T patent/DK0828511T3/da active
- 1996-05-24 EA EA199700419A patent/EA000411B1/ru not_active IP Right Cessation
- 1996-05-24 NZ NZ309829A patent/NZ309829A/xx not_active IP Right Cessation
- 1996-05-24 DE DE201112100030 patent/DE122011100030I1/de active Pending
- 1996-05-24 PL PL96323457A patent/PL185846B1/pl unknown
- 1996-05-24 PT PT96917554T patent/PT828511E/pt unknown
- 1996-05-24 DE DE69620271T patent/DE69620271T2/de not_active Expired - Lifetime
- 1996-05-24 SK SK1529-97A patent/SK282500B6/sk not_active IP Right Cessation
- 1996-05-24 HU HU9901432A patent/HU223941B1/hu active Protection Beyond IP Right Term
- 1996-05-24 CN CNB961955821A patent/CN1152715C/zh not_active Expired - Lifetime
- 1996-05-24 TR TR97/01424T patent/TR199701424T1/xx unknown
- 1996-05-24 ES ES96917554T patent/ES2162067T3/es not_active Expired - Lifetime
- 1996-05-24 JP JP8535452A patent/JPH11505824A/ja not_active Ceased
- 1996-05-24 WO PCT/FR1996/000791 patent/WO1996037222A1/fr not_active Ceased
- 1996-05-24 BR BRPI9608810-9C8A patent/BR9608810C8/pt not_active IP Right Cessation
- 1996-05-24 EP EP96917554A patent/EP0828511B1/fr not_active Expired - Lifetime
- 1996-05-24 KR KR1019970708265A patent/KR100404312B1/ko not_active Expired - Lifetime
- 1996-05-24 US US08/952,602 patent/US6333036B1/en not_active Expired - Lifetime
1997
- 1997-11-21 NO NO19975366A patent/NO319579B1/no not_active IP Right Cessation
2001
- 2001-10-25 GR GR20010401748T patent/GR3037011T3/el unknown
2006
- 2006-05-09 NL NL300231C patent/NL300231I2/nl unknown
2011
- 2011-09-19 NO NO2011019C patent/NO2011019I2/no not_active IP Right Cessation
- 2011-12-21 LU LU91924C patent/LU91924I2/fr unknown

Also Published As

Publication number	Publication date
SK282500B6 (sk)	2002-10-08
FR2734484B1 (fr)	1997-06-27
DE69620271D1 (de)	2002-05-02
CZ359797A3 (cs)	1999-06-16
NO2011019I2 (no)	2015-05-18
EA000411B1 (ru)	1999-06-24
CZ289810B6 (cs)	2002-04-17
PL323457A1 (en)	1998-03-30
CA2218764C (fr)	2011-01-11
NO319579B1 (no)	2005-08-29
DE122011100030I1 (de)	2011-12-08
AU6008696A (en)	1996-12-11
ES2162067T3 (es)	2001-12-16
ATE207365T1 (de)	2001-11-15
HUP9901432A2 (hu)	1999-08-30
HK1017251A1 (en)	1999-11-19
FR2734484A1 (fr)	1996-11-29
CA2218764A1 (fr)	1996-11-28
NL300231I1 (nl)	2006-07-03
JPH11505824A (ja)	1999-05-25
EP0828511B1 (fr)	2001-10-24
PL185846B1 (pl)	2003-08-29
SK152997A3 (en)	1998-07-08
NO975366D0 (no)	1997-11-21
DE69620271T2 (de)	2002-07-18
TR199701424T1 (xx)	1998-03-21
BR9608810C8 (pt)	2014-07-08
WO1996037222A1 (fr)	1996-11-28
US6333036B1 (en)	2001-12-25
EA199700419A1 (ru)	1998-06-25
NL300231I2 (nl)	2006-09-01
HUP9901432A3 (en)	2000-03-28
BR9608810A (pt)	1999-08-31
NO2011019I1 (no)	2011-09-26
AU708777B2 (en)	1999-08-12
GR3037011T3 (en)	2002-01-31
NZ309829A (en)	1999-06-29
CN1152715C (zh)	2004-06-09
PT828511E (pt)	2002-02-28
KR100404312B1 (ko)	2004-02-11
MX9709011A (es)	1998-03-31
KR19990014919A (ko)	1999-02-25
HU223941B1 (hu)	2005-03-29
DK0828511T3 (da)	2002-02-18
CN1190898A (zh)	1998-08-19
EP0828511A1 (fr)	1998-03-18
LU91924I2 (fr)	2012-02-21

Legal Events

Date

Code

Title

Description

2011-09-26

SPCF

Filing of supplementary protection certificate

Free format text: PRODUCT NAME: PEDIACEL; NAT. REG. NO/DATE: 09-7174 20110321; FIRST REG. NO/DATE: PL06745/0120 20021016

Spc suppl protection certif: 2011019

Filing date: 20110919

2015-05-18

SPCG

Granted supplementary protection certificate